NYSE:MED - Medifast Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $271.33
  • Forecasted Upside: 6.51 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$254.75
▼ -8.6 (-3.27%)
1 month | 3 months | 12 months
Get New Medifast Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MED

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$271.33
▲ +6.51% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Medifast in the last 3 months. The average price target is $271.33, with a high forecast of $310.00 and a low forecast of $239.00. The average price target represents a 6.51% upside from the last price of $254.75.
Buy
The current consensus among 3 investment analysts is to buy stock in Medifast. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2021B. RileyBoost Price TargetBuy$300.00 ➝ $310.00Medium
i
2/19/2021B. RileyBoost Price TargetBuy$250.00 ➝ $300.00Low
i
1/25/2021Jefferies Financial GroupUpgradeHold ➝ Buy$205.00 ➝ $265.00High
i
1/12/2021DA DavidsonBoost Price TargetPositive ➝ Buy$205.00 ➝ $239.00Medium
i
Rating by L. Weiser at DA Davidson
11/5/2020DA DavidsonUpgradeNeutral ➝ Buy$180.00 ➝ $205.00High
i
Rating by L. Weiser at DA Davidson
11/3/2020B. RileyBoost Price TargetBuy$230.00 ➝ $250.00High
i
Rating by K. Anderson at B. Riley
10/9/2020B. RileyBoost Price Target$220.00 ➝ $230.00Medium
i
Rating by K. Anderson at B. Riley
10/1/2020Jefferies Financial GroupUpgradeBuy$210.00Medium
i
8/10/2020DA DavidsonBoost Price TargetNeutral$86.00 ➝ $180.00Low
i
8/6/2020B. RileyBoost Price Target$164.00 ➝ $220.00Medium
i
Rating by K. Anderson at B. Riley
6/25/2020B. RileyInitiated CoverageBuy$164.00High
i
Rating by K. Anderson at B. Riley
5/6/2020DA DavidsonBoost Price TargetNeutral$83.00 ➝ $86.00High
i
Rating by L. Weiser at DA Davidson
2/27/2020DA DavidsonBoost Price TargetNeutral$74.00 ➝ $83.00High
i
Rating by L. Weiser at DA Davidson
2/27/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$130.00 ➝ $90.00High
i
1/14/2020Jefferies Financial GroupBoost Price TargetBuy$110.00 ➝ $130.00High
i
11/8/2019Dougherty & CoDowngradeBuy ➝ NeutralHigh
i
11/8/2019DA DavidsonDowngradeBuy ➝ Neutral$250.00 ➝ $74.00High
i
Rating by Linda Bolton Weiser at DA Davidson
9/23/2019DA DavidsonSet Price TargetBuy$250.00Medium
i
Rating by Linda Bolton Weiser at DA Davidson
9/13/2019DA DavidsonSet Price TargetBuy$250.00Low
i
Rating by Linda Bolton Weiser at DA Davidson
7/25/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$130.00Medium
i
2/27/2019SidotiBoost Price TargetBuy ➝ Buy$211.00 ➝ $216.00High
i
11/8/2018SidotiUpgradeNeutral ➝ BuyMedium
i
8/3/2018DA DavidsonBoost Price TargetBuy$249.00Low
i
7/23/2018DA DavidsonBoost Price TargetBuy$201.00Medium
i
5/24/2018DA DavidsonBoost Price TargetBuy ➝ Buy$135.00 ➝ $161.00High
i
5/4/2018DA DavidsonBoost Price TargetBuy$135.00High
i
4/19/2018SidotiReiterated RatingBuy ➝ NeutralMedium
i
3/8/2018DA DavidsonBoost Price TargetBuy$108.00High
i
3/7/2018SidotiUpgradeNeutral ➝ BuyHigh
i
12/8/2017DA DavidsonBoost Price TargetBuy$89.00Medium
i
Rating by L. Weiser at DA Davidson
9/21/2017SidotiReiterated RatingNeutral$49.00 ➝ $55.00Low
i
9/15/2017DA DavidsonBoost Price TargetBuy ➝ Buy$65.00 ➝ $74.00High
i
Rating by L. Weiser at DA Davidson
8/16/2017DA DavidsonInitiated CoverageBuyHigh
i
Rating by L. Weiser at DA Davidson
5/2/2017SidotiDowngradeBuy ➝ NeutralLow
i
8/4/2016WunderlichBoost Price TargetHold$32.00 ➝ $36.00N/A
i
(Data available from 2/26/2016 forward)
Medifast logo
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through direct ecommerce platform and franchise weight control center channels. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Read More

Today's Range

Now: $254.75
$254.75
$268.64

50 Day Range

MA: $239.93
$207.43
$274.30

52 Week Range

Now: $254.75
$49.03
$279.46

Volume

119,080 shs

Average Volume

125,809 shs

Market Capitalization

$3.00 billion

P/E Ratio

31.88

Dividend Yield

1.72%

Beta

1.52

Frequently Asked Questions

What sell-side analysts currently cover shares of Medifast?

The following Wall Street research analysts have issued research reports on Medifast in the last twelve months: B. Riley, DA Davidson, Jefferies Financial Group Inc., and Zacks Investment Research.
View the latest analyst ratings for MED.

What is the current price target for Medifast?

3 Wall Street analysts have set twelve-month price targets for Medifast in the last year. Their average twelve-month price target is $268.00, suggesting a possible upside of 1.8%. B. Riley has the highest price target set, predicting MED will reach $300.00 in the next twelve months. DA Davidson has the lowest price target set, forecasting a price of $239.00 for Medifast in the next year.
View the latest price targets for MED.

What is the current consensus analyst rating for Medifast?

Medifast currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MED will outperform the market and that investors should add to their positions of Medifast.
View the latest ratings for MED.

What other companies compete with Medifast?

How do I contact Medifast's investor relations team?

Medifast's physical mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer's listed phone number is 410-581-8042 and its investor relations email address is [email protected] The official website for Medifast is www.medifast1.com.